CEO Kristen Fortney was paid $2,886,590 in fiscal year 2025, ↓ down 76.4% from fiscal year 2024 (SEC filing 0001193125-26-166738 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$2,886,590 ↓ Kristen Fortney total, FY2025 | — CEO pay percentile vs peers | — CEO-to-median pay ratio | — Say-on-pay support, latest vote |
You have just read BioAge Labs's Summary Compensation Table. The whole free brief as a PDF, sent in 2 minutes, with every figure cited — then a few short notes on the deeper BIOA reports.
We send the PDF within 2 minutes, then up to three short notes. Reply “unsubscribe” to any of them, any time.
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
BIOA's next annual pay disclosure, estimated April 21, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Kristen Fortney | $600,000 | $0 | $0 | $1,941,390 | $330,000 | $0 | $15,200 | $2,886,590 |
| Chief Executive Officer and President | ||||||||
| Paul Rubin | 520,200 | 0 | 0 | 732,600 | 208,080 | 0 | 15,200 | 1,476,080 |
| Chief Medical Officer | ||||||||
| Eric Morgen | 499,600 | 0 | 0 | 732,600 | 199,840 | 0 | 15,200 | 1,447,240 |
| Chief Operating Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Kristen Fortney | $2,886,590 | $12,226,906 | — | ↓ −9,340,316 |
| Paul Rubin | 1,476,080 | 1,923,841 | — | ↓ −447,761 |
| Eric Morgen | 1,447,240 | 2,465,347 | — | ↓ −1,018,107 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
How we handle your data → Privacy
Each company listed discloses BIOA in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named BIOA in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| James I. Healy, M.D., Ph.D | Independent Director | $137,752 |
| Jean-Pierre Garnier, Ph.D | Chair of the Board | $172,752 |
| Michael Davidson, M.D | Independent Director | $138,752 |
| Patrick Enright, M.B.A | Independent Director | $129,252 |
| Rekha Hemrajani, M.B.A | Independent Director | $141,752 |
| Vijay Pande, Ph.D | Independent Director | $114,007 |
No insider equity transactions reported since the proxy statement.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Kristen Fortney | Option | 7,229 | 7.23 | — |
| Kristen Fortney | Option | 36,141 | 10.85 | — |
| Kristen Fortney | Option | 413,026 | 8.39 | — |
| Kristen Fortney | Option | 292,069 | 18 | — |
| Kristen Fortney | Option | 408,542 | 4.38 | — |
| Eric Morgen | Option | 2,680 | 6.57 | — |
| Eric Morgen | Option | 13,396 | 10.85 | — |
| Eric Morgen | Option | 150,485 | 8.39 | — |
| Eric Morgen | Option | 154,167 | 4.38 | — |
| Paul Rubin | Option | 1,712 | 6.57 | — |
| Paul Rubin | Option | 8,558 | 10.85 | — |
| Paul Rubin | Option | 102,637 | 8.39 | — |
| Paul Rubin | Option | 154,167 | 4.38 | — |
Base salary is the only fixed component of total cash compensation and provides competitive and stable pay to attract and retain executives. A portion of target compensation is in the form of an annual cash bonus based on the achievement of corporate and individual performance.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Alpine Rewards LLC |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | false |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-10 | — | — | — | — | — |
| 2025 | 2025-06-05 | — | — | — | — | — |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-10 | —a |
| 2025 | 2025-06-05 | —b |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Jean-Pierre Garnier, Ph.DIndependent · Board Chair · Compensation · Nominating and Governance | $91,000 | — | $81,752 | — | — | $172,752 |
| Rekha Hemrajani, M.B.AIndependent · Audit (Chair) · Nominating and Governance | 60,000 | — | 81,752 | — | — | 141,752 |
| Michael Davidson, M.DIndependent · Compensation (Chair) · Nominating and Governance | 57,000 | — | 81,752 | — | — | 138,752 |
| James I. Healy, M.D., Ph.DIndependent · Compensation · Nominating and Governance (Chair) | 56,000 | — | 81,752 | — | — | 137,752 |
| Patrick Enright, M.B.AIndependent · Audit | 47,500 | — | 81,752 | — | — | 129,252 |
| Vijay Pande, Ph.DIndependent · Audit | 35,625 | — | 78,382 | — | — | 114,007 |
| Eric Morgen, M.DEmployee director | — | — | — | — | — | 0 |
| Kristen Fortney, Ph.DEmployee director | — | — | — | — | — | 0 |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 12,000 / 10,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $347,125 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $347,125 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | BioAge Labs | 2025 | Kristen Fortney | $600,000 | $0 | $1,941,390 | $330,000 | $2,886,590 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Kristen Fortney | DEF 14A | 2026-04-21 | 0001193125-26-166738 | Section “Executive Compensation”. As printed: 2,886,590. Filing ↗machine: r2 · c19 · span 428555–428564 |
| 2 | Section 01, Paul Rubin | DEF 14A | 2026-04-21 | 0001193125-26-166738 | Section “Executive Compensation”. As printed: 1,476,080. Filing ↗machine: r6 · c19 · span 459062–459071 |
| 3 | Section 01, Eric Morgen | DEF 14A | 2026-04-21 | 0001193125-26-166738 | Section “Executive Compensation”. As printed: 1,447,240. Filing ↗machine: r4 · c19 · span 443811–443820 |
| 4 | Section 08, Jean-Pierre Garnier, Ph.D | DEF 14A | 2026-04-21 | 0001193125-26-166738 | Section “Director Compensation”. As printed: 172,752. Filing ↗machine: span 235533–235742 |
| 5 | Section 08, Rekha Hemrajani, M.B.A | DEF 14A | 2026-04-21 | 0001193125-26-166738 | Section “Director Compensation”. As printed: 141,752. Filing ↗machine: span 253977–254186 |
| 6 | Section 08, Michael Davidson, M.D | DEF 14A | 2026-04-21 | 0001193125-26-166738 | Section “Director Compensation”. As printed: 138,752. Filing ↗machine: span 240143–240352 |
| 7 | Section 08, James I. Healy, M.D., Ph.D | DEF 14A | 2026-04-21 | 0001193125-26-166738 | Section “Director Compensation”. As printed: 137,752. Filing ↗machine: span 244755–244964 |
| 8 | Section 08, Patrick Enright, M.B.A | DEF 14A | 2026-04-21 | 0001193125-26-166738 | Section “Director Compensation”. As printed: 129,252. Filing ↗machine: span 249366–249575 |
| 9 | Section 08, Vijay Pande, Ph.D | DEF 14A | 2026-04-21 | 0001193125-26-166738 | Section “Director Compensation”. As printed: 114,007. Filing ↗machine: span 258743–258952 |
| 10 | Section 08, Eric Morgen, M.D | DEF 14A | 2026-04-21 | 0001193125-26-166738 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 11 | Section 08, Kristen Fortney, Ph.D | DEF 14A | 2026-04-21 | 0001193125-26-166738 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 12 | Section 06, 2026 vote | Form 8-K | 2026-06-12 | 0001193125-26-268518 | Item 5.07 · say-on-pay result. As reported: —. Filing ↗ |
| 13 | Section 06, 2025 vote | Form 8-K | 2025-06-09 | 0000950170-25-083746 | Item 5.07 · say-on-pay result. As reported: —. Filing ↗ |
| 14 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 15 | Section 09b board cost (computed) | Computed | — | — | Cash 347,125 + equity 0 + all other 0 = 347,125, summed across the director compensation table rows.machine: formula: Σ = 347,125 |
| 16 | BioAge Labs (subject), Section 10b CEO total | DEF 14A | 2026-04-21 | 0001193125-26-166738 | CEO total compensation as printed in BioAge Labs's own proxy. As printed: 2,886,590. Filing ↗machine: r2 · c19 · span 428555–428564 |